HHS, DOD Collaborate With Merck to Continue the Development and Large-Scale Manufacturing of Investigational COVID-19 Treatment
Posted on
The Department of the Health and Human Services and the Defense Department jointly announced an agreement with Merck to support advanced development and large-scale manufacturing of the their investigational therapeutic MK-7110 to treat hospitalized patients with severe or critical COVID-19.
Subscribe to our newsletter
Promotions, new products and sales. Directly to your inbox.
Quick links
© Copyright 2024, Morale Patch® Armory.